<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01010763</url>
  </required_header>
  <id_info>
    <org_study_id>INT.CR.RROW2</org_study_id>
    <nct_id>NCT01010763</nct_id>
  </id_info>
  <brief_title>A Study on M2a Magnum Total Hip Arthroplasty</brief_title>
  <official_title>A Prospective Controlled Multi-Center Study on M2a Magnum Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biomet Japan, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study includes the investigation of Metal-ion release and Renal Function
      analysis in M2a Total Hip Arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are no clinical studies conducted on its performance in Asian population. Furthermore
      clinical data is required to support marketing and validate design of M2A Magnum.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Range of Motion</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metal Ion</measure>
    <time_frame>3m,6m,1y,2y,3y,4y,5y</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCLA Activity Score, EQ5D</measure>
    <time_frame>3m,6m,1y,2y,3y,4y,5y</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Assessment</measure>
    <time_frame>Immediate post-op,3m,6m,1y,2y,3y,4y,5y</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>3m,6m,1y,2y,5y</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">184</enrollment>
  <condition>Degenerative Joint Disease</condition>
  <condition>Avascular Necrosis</condition>
  <arm_group>
    <arm_group_label>M2a Magnum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total HIp Arthroplasty using with the M2a Magnum Large Metal Articulation is an ultra-high performance metal-on-metal articulation with a big ball (greater than or equal to 38mm) in acetabulums as small as 44mm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>M2a Taper</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total Hip Arthroplasty using with the M2a Taper Acetabular System consists of a titanium outer shell with cobalt chromium (Co-Cr-Mo) metallic liner, which articulates with with a cobalt chromium (Co-Cr-Mo) modular femoral head.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total Hip Arthroplasty</intervention_name>
    <description>Degenerated hip is replaced with implantable devices, which include femoral stem, acetabular cup, femoral head and acetabular liner(control group only).</description>
    <arm_group_label>M2a Magnum</arm_group_label>
    <arm_group_label>M2a Taper</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suitable for primary Total Hip Replacement

          -  Patients aged over 20

          -  Patients with limited co-morbidity- ASA I-III

          -  Patients must be able to understand instructions and be willing to return for
             follow-up

          -  Patients willing to provide blood and urine samples for metal ion analysis at
             follow-up

        Exclusion Criteria:

          -  Pre-existing metal implants

          -  Infection, sepsis, and osteomyelitis

          -  Uncooperative patient or pt with neurologic disorders who are incapable of following
             directions

          -  Osteoporosis

          -  Metabolic disorders which may impair bone formation

          -  osteomalacia

          -  distant foci of infections which may spread to the implant site

          -  rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

          -  vascular insufficiency, muscular atrophy, or neuromuscular disease

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenji Ozono, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kansai Rosai Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kansai Rosai Hospital</name>
      <address>
        <city>Amagasaki</city>
        <state>Hyogo Pref.</state>
        <zip>660-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2009</study_first_submitted>
  <study_first_submitted_qc>November 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2009</study_first_posted>
  <last_update_submitted>September 26, 2016</last_update_submitted>
  <last_update_submitted_qc>September 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 12, 2017</submitted>
    <returned>November 28, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

